Protective effects of curcumin and beta-carotene on cisplatin-induced cardiotoxicity: An experimental rat model

Furthermore, these findings revealed that treatment with CMN has a higher cardioprotective effect than that with BC againstCDDP-induced cardiotoxicity in rat cardiac tissues.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Objective: Cisplatin (CDDP) has been known to be an effective antineoplastic drug; however, it has a cardiotoxic effect.

📊

Key Findings & Data:The current study was conducted toevaluate the possible protective roles of CMN and BC on CDDP-induced cardiotoxicity in rat cardiac tissues.Methods: A total of 49 adult female Wistar albino rats were equally divided into seven groups as follows: control (no medication), sesame oil (1mg/kg), CDDP (single dose injection two times as once a week, 5 mg/kg/week), BC (100 mg/kg), CDDP+BC (pretreated BC for 30 min before CDDPinjection), CMN (200 mg/kg), and CDDP+CMN (pretreated CMN for 30 min before CDDP injection).

💡

Conclusion & Impact:Furthermore, these findings revealed that treatment with CMN has a higher cardioprotective effect than that with BC againstCDDP-induced cardiotoxicity in rat cardiac tissues.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Özet

Objective: Cisplatin (CDDP) has been known to be an effective antineoplastic drug; however, it has a cardiotoxic effect. Curcumin (CMN) andbeta-carotene (BC) have been suggested to protect biological systems against CDDP-induced damage. The current study was conducted toevaluate the possible protective roles of CMN and BC on CDDP-induced cardiotoxicity in rat cardiac tissues.Methods: A total of 49 adult female Wistar albino rats were equally divided into seven groups as follows: control (no medication), sesame oil (1mg/kg), CDDP (single dose injection two times as once a week, 5 mg/kg/week), BC (100 mg/kg), CDDP+BC (pretreated BC for 30 min before CDDPinjection), CMN (200 mg/kg), and CDDP+CMN (pretreated CMN for 30 min before CDDP injection). These treatments were applied intraperitoneallyfor CDDP and with gavage for CMN and BC. The oxidative/antioxidant indicators, inflammatory cytokines, and histopathological alterationswere examined.Results: These alterations included a marked increase in malondialdehyde (MDA) level, significant decrease in catalase (CAT) and superoxidedismutase (SOD) activities, and significant elevation of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, interleukin (IL)-6 in the CDDP groupcompared with the other groups. Histopathologically, CDDP-induced severe myocardial degenerative changes were observed. However, theCDDP-induced disturbances in the above-mentioned parameters significantly improved by treatment with BC and particularly CMN.Conclusion: This study indicated that CDDP treatment markedly caused cardiotoxicity; however, treatment with CMN or BC ameliorated this cardiotoxicityin rats. Furthermore, these findings revealed that treatment with CMN has a higher cardioprotective effect than that with BC againstCDDP-induced cardiotoxicity in rat cardiac tissues.

🔖

Cite This Article

BAHADIR, A., CEYHAN, A., GERGİN, Ö. Ö., YALÇIN, B., ÜLGER, M., ÖZYAZGAN, T. M., YAY, A. (2018). Protective effects of curcumin and beta-carotene on cisplatin-induced cardiotoxicity: An experimental rat model. The Anatolian Journal of Cardiology, Cilt: 19 - Sayı: 3, 213–221. https://ajindex.com/articles/357822

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (5)

Misotti AM, Gnagnarella P. Vitamin supplement consumption and breast cancer risk: a review. Ecancermedicalscience 2013; 7: 365. Gallicchio L, Boyd K, Matanoski G, Tao XG, Chen L, Lam TK, et al. Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr 2008; 88: 372-83. [CrossRef] Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-5. [CrossRef] Zhang PY, Xu X, Li XC. Cardiovascular diseases: oxidative damage and antioxidant protection. Eur Rev Med Pharmacol Sci 2014; 18: 3091-6.
Kim SK, Park HJ, Joo SY, Hong MH, Kim KH, Hong YJ, et al. The protective effect of curcumin on myocardial ischemia-perfusion injury. Korean Circ J 2008; 38: 353-59. [CrossRef] Bashandy MA, Amin SA, Seleem H. Cardiotoxic effect of Chlorpromazine in adult male Albino rats and the possible Curcumin cardioprotection (histological, histochemical and immunohistochemical study). J Am Sci 2012; 8: 888-97.
Saleh RM, Awadin WF, Elseady YY, Waheish FE. Renal and cardiovascular damage induced by cisplatin in rats. Life Sci J 2014; 11: 191-203.
Ghandadi M, Sahebkar A. Curcumin: An effective inhibitor of interleukin-6. Curr Pharm Des 2017; 23: 921-31. [CrossRef] Wang NP, Pang XF, Zhang LH, Tootle S, Harmouche S, Zhao ZQ. Attenuation of inflammatory response and reduction in infarct size by postconditioning are associated with downregulation of early growth response 1 during reperfusion in rat heart. Shock 2014; 41: 346-54. [CrossRef] Song Y, Ge W, Cai H, Zhang H. Curcumin protects mice from coxsackievirus B3-induced myocarditis by inhibiting the phosphatidylinositol 3 kinase/Akt/nuclear factor-κB pathway. J Cardiovasc Pharmacol Ther 2013; 18: 560-9. [CrossRef] Li HL, Liu C, de Couto G, Ouzounian M, Sun M, Wang AB, et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest 2008; 118: 879-93. [CrossRef] Gupta SC, Tyagi AK, Deshmukh-Taskar P, Hinojosa M, Prasad S, Aggarwal BB. Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols. Arch Biochem Biophys 2014; 559: 91-9. [CrossRef] Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol 2008; 75: 787-809.
Benedetti G, Fredriksson L, Herpers B, Meerman J, van de Water B, de Graauw M. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation